CXCL12 and esophageal squamous cell carcinoma: CXCL12, known to be induced by IGF2 and to promote immune suppression [39], overlapped with IGF1 expression rather than IGF2 in ESCC, suggesting a possible link between interCAFs IGF signaling and immunomodulation in this cancer.